Cefepime microbiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 18: | Line 18: | ||
*[[Streptococcus pneumoniae]] | *[[Streptococcus pneumoniae]] | ||
*[[Streptococcus pyogenes]] (Lancefield’s Group A streptococci) | *[[Streptococcus pyogenes]] (Lancefield’s Group A streptococci) | ||
*[[Viridans group streptococci]]. | *[[Streptococcus viridans|Viridans group streptococci]]. |
Revision as of 16:01, 18 December 2013
Microbiology
Cefepime is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefepime has a broad spectrum of in vitro activity that encompasses a wide range of Gram-positive and Gram-negative bacteria. Cefepime has a low affinity for chromosomally-encoded beta-lactamases. Cefepime is highly resistant to hydrolysis by most beta-lactamases and exhibits rapid penetration into Gram-negative bacterial cells. Within bacterial cells, the molecular targets of cefepime are the penicillin binding proteins (PBP).
Susceptible organisms
Aerobic Gram-Negative Microorganisms:
Aerobic Gram-Positive Microorganisms:
- Staphylococcus aureus (methicillin-susceptible isolates only)
- Streptococcus pneumoniae
- Streptococcus pyogenes (Lancefield’s Group A streptococci)
- Viridans group streptococci.